Mr. Speaker, drug shortages are a public health issue.
In recent years, those shortages have had a significant impact on the health of Canadians, the practices of health care professionals and system costs.
The NDP wants pharmaceutical companies to be required to report any disruption in the drug supply.
Will the government support our bill, which is designed to protect the health and safety of Canadians?